Julio Rodríguez

Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ _25-35 non-transgenic mouse model of Alzheimer’s disease

Tangui Maurice, Muhammad-Hariri Mustafa, Catherine Desrumaux et al. · Journal of Psychopharmacology · 2013 · 89 citations

Medicine, Neuroscience, Pharmacology +17

Oral Zinc Sulphate Supplementation for Six Months in SCA2 Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

Luis Velázquez‐Pérez, Jorge Enrique Rodríguez Chanfrau, Julio Rodríguez et al. · Neurochemical Research · 2011 · 40 citations

Medicine, Pharmacology, Pharmacotherapy +9

Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study

Orestes Santos Morales, Alina Díaz-Machado, Daise Jiménez-Rodríguez et al. · BMC Neurology · 2017 · 39 citations · Full text

Medicine, Neuroscience, Pharmacology +15

Changes in the expression level of MAPK pathway components induced by monosodium glutamate-administration produce neuronal death in the hippocampus from neonatal rats

Martha Catalina Rivera-Carvantes, José Jaime Jarero-Basulto, Alfredo Feria‐Velasco et al. · Neuroscience · 2017 · 17 citations

Life Sciences, Neurobiology, Neuroscience +17

Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study

Roberto Rodríguez‐Labrada, Ricardo Ortega-Sánchez, Patricia Hernández Casaña et al. · Movement Disorders · 2022 · 14 citations

Medicine, Neurology, Pharmacology +10